This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Martín de las Mulas, J. Articles by Dios, R. Search for Related Content PubMed PubMed Citation Articles by Martín de las Mulas, J. Articles by Dios, R.

A Prospective Analysis of Immunohistochemically Determined Estrogen Receptor and Progesterone Receptor Expression and Host and Tumor Factors as Predictors of Disease-free Period in Mammary Tumors of the Dog

Department of Comparative Pathology, Veterinary School (JMM, YM) and Department of Statistics, Econometric, Operative Research and Business Organization, Agricultural School (RD), University of Córdoba, Córdoba, Spain

The immunohistochemically determined estrogen receptor (ER) (ER) and progesterone receptor (PR) status, as well as recognized, well-accepted prognostic indicators and host factors were prospectively analyzed in 84 cases of primary canine mammary carcinoma for their effect on disease-free period (recurrence free, metastasis free, or combined) (DFP) after an observation period of 18 months. The presence of one or both receptors, as well as tumor size, lymph node status, histologic grading, intravascular growth, and necrosis, were of prognostic value for DFP. In multivariate analysis, only tumor size and histologic grading proved to be independent prognosticators. None of the host factors analyzed were of prognostic value for DFP. ER, PR, or both were detected in 173 out of 228 tumors: 70 ER and PR; 5 ER only; 98 PR only. Statistically significant differences regarding the presence of one or both receptors were observed between benign and malignant tumors and between complex, mixed, and simple histologic subtypes of benign and malignant tumors. In the group of malignant tumors (n = 155), the presence of one or both receptors was more frequent in tumors smaller than 3 cm, without lymph node metastasis, with tubulopapillary rather than solid patterns of growth among simple carcinomas, of histologic grades I and II, without both intravascular growth and necrosis, and with lymphocyte cell infiltrates. The most frequent groups of hormone receptors–positive tumors were the ER-positive and PR-positive group among benign and the ER-negative and PR-positive group among malignant tumors.

Key words: Canines; carcinoma; estrogen; immunohistochemistry; mammary glands; progesterone; prognosis; receptors.

Request reprints from Dr. Juana Martín de las Mulas, Dpto. de Anatomía y Anatomía Patológica Comparadas, Facultad de Veterinaria, Universidad de Córdoba, Sanidad Animal, Campus de Rabanales, Carretera de Madrid-Cádiz, Km. 396, 14014 Córdoba (Spain). E-mail: an1magoj{at}uco.es

This article has been cited by other articles:

				M. G. Asakawa, M. H. Goldschmidt, Y. Une, and Y. Nomura The Immunohistochemical Evaluation of Estrogen Receptor-{alpha} and Progesterone Receptors of Normal, Hyperplastic, and Neoplastic Endometrium in 88 Pet Rabbits Vet. Pathol., March 1, 2008; 45(2): 217 - 225. [Abstract] [Full Text] [PDF]

				E. Antuofermo, M. A. Miller, S. Pirino, J. Xie, S. Badve, and S. I. Mohammed Spontaneous Mammary Intraepithelial Lesions in Dogs A Model of Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2247 - 2256. [Abstract] [Full Text] [PDF]

				M. Brunelle, E. A. Sartin, L. G. Wolfe, J. Sirois, and M. Dore Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines. Vet. Pathol., September 1, 2006; 43(5): 656 - 666. [Abstract] [Full Text] [PDF]